- About Us
- Contact Us
Advance New Southbound, Taiwan and Vietnam facilitate exchange and collaboration on tuberculosis prevention and control
According to the World Health Organization (WHO), over 10 million people worldwide fell ill with tuberculosis in 2016. Among them, most of the cases occurred in New Southbound countries in Southeast Asia and the Western Pacific Region. Vietnam is a country with a high burden of tuberculosis and multidrug-resistant tuberculosis.
In recent years, Taiwan has been actively implementing the Directly Observed Treatment Short-course (DOTS) program, treatment of latent tuberculosis infection for high-risk group and multidrug-resistant tuberculosis medical care. Through the joint efforts of our public health workers and healthcare system, our TB incidence rate has decreased to below 10,000 people in 2017 (9,759).
CDC assists Vietnam for combating multidrug-resistant tuberculosis. In this year 2018, Wanfang Hospital and related teams were formed to multidrug-resistant tuberculosis medical care system for practical cooperation. Workshop participants will be exchanging practices to CDC Regional Centers, Department of Health, New Taipei City Government and Department of Health, Kaohsiung City Government. Through the participation from the north to the south, they know more about how Taiwan combine central, local, medical and private resources, they also come to Wanfang Hospital for clinical and laboratory cooperation on tuberculosis prevention and treatment for two weeks, including latent mycobacterium tuberculosis infection detection, diagnosis of tuberculosis, treatment and side effects of drugs, diagnosis of multidrug-resistant tuberculosis, biosafety of tuberculosis laboratory and infection control.
In the second half of the year, Taiwan will send a team of epidemic prevention doctors to Vietnam for field guidance, carry out epidemic prevention, enhance the capacity of regional joint prevention of tuberculosis through two-way cooperation, will help reinforce the regional capacity to tackle tuberculosis, lower the cross-border tuberculosis threat, and achieve the global goal of End TB 2035.